Arterial Hypertension


An antihypertensive drug given subcutaneously every 6 months 


Hypertension affects 30-45% of adults and is the most important modifiable risk factor for cardiovascular disease, primarily stroke and myocardial infarction.

The global burden of disease is heavy, with a global prevalence of over one billion and around 9 million deaths attributed to hypertension annually.

Currently available pharmacological therapies only achieve target blood pressure in a minority of cases, largely due to the patient not taking their medication properly. Poor adherence to oral antihypertensive drugs is associated with poor cardiovascular outcomes and is prevalent at all stages of the disease.

Thus, the development of new approaches to treat hypertension and overcome the limitations of current therapies is a key unmet need.

We are conducting a clinical study to assess the efficacy and safety of the drug in participants with mild to moderate hypertension. We are conducting this study to support the development of an investigational blood pressure injection drug that will be revolutionary in healthcare.

To participate, you must:

  • Be between 18 and 75 years old
  • Have untreated hypertension or is under stable treatment with 1 or more antihypertensive drugs

You will be given reimbursement for study-related expenses when you participate in the clinical study and you will be surrounded by a medical team throughout the process.

I want to apply to this clinical study


For more information, contact us at
819 346-2887 (Sherbrooke), 581 477-3439 (Québec), 819 801-9797 (Trois-Rivières), 819 260-1172 (Victoriaville)
or at 1-844-739-3439 (toll free), or fill the online form.

The study process in pictures


Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.


Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.


Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.


Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.


Step 5 | If you are eligible, you may then begin a clinical study with us.